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Cardiac Imaging and
Cardiac Resynchronization Therapy
Time to Get in Phase*
Barry L. Zaret, MD, FACC
New Haven, ConnecticutIn this issue of iJACC (JACC: Cardiovascular Imag-
ing), Botvinick et al. (1) perform a complex study
involving the performance of equilibrium radionu-
clide myocardiography with phase analysis during
ventricular tachycardia. The authors identify spe-
cific characteristics that define tolerability of the
arrhythmia in individual patients. Most of these
discriminating factors in the 2 patient groups in-
volve changes in classic hemodynamic measure-
ments such as ejection fraction, stroke volume,
cardiac output, and end-diastolic volume during the
arrhythmia when compared with the basal state.
Heterogeneity in regional contraction, as defined by
phase analysis, was discriminating between groups
only in the resting state. The exit site of the
ventricular tachycardia could be defined in approx-
imately 80% of arrhythmias. The authors conclude
that this type of image analysis offers substantial
physiologic information concerning the ability of a
patient to tolerate a rhythm disturbance.
See page 605
In addition, with respect to clinical relevance,
they posit that such an imaging approach could
provide clinical insight in heart failure patients
considered for cardiac resynchronization therapy
(CRT), with a view toward defining which individ-
uals would benefit from this procedure. It is this
potential that appears to excite the authors with
respect to the future application of the imaging
technique.
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.From the Section of Cardiovascular Medicine, Department of Internal
Medicine, Yale University School of Medicine, New Haven, Connecticut.Cardiac resynchronization is a relatively recent
major advance in the treatment of advanced con-
gestive heart failure, specifically those with signifi-
cant symptoms, depression of ejection fraction, and
prolonged QRS duration on the surface electrocar-
diogram (2). Recent clinical trials have demon-
strated that CRT can lead to major symptom
improvement as well as provide a mortality benefit
in patients with severe congestive heart failure
(3–8). However, these previous studies also have
demonstrated that 20% to 30% of patients who
were deemed suitable for CRT will not receive
benefit from this therapy.
The definition of these 20% to 30% of patients
receiving CRT with no clinical improvement but
considerable clinical cost presents an immediate
clinical need. Major attempts in the imaging com-
munity have centered on developing appropriate
noninvasive surrogate markers that might enrich
the selection process of those suitable for this
expensive therapy. The magnitude of the problem is
very significant when one considers that the inci-
dence of congestive heart failure continues to grow
dramatically within the U.S. (9). Currently there are
more than 5 million patients afflicted by this con-
dition, with approximately 550,000 new cases an-
nually. Hospitalization for congestive heart failure
involves more than 1 million admissions per year.
Comparable with the case of patient selection for
implantable defibrillators, a more accurate and pre-
cise definition of those who will benefit is both a
clinical and economic necessity. As in most in-
stances of clinical medicine and evidence-based
algorithms, extracting data derived from large pop-
ulations, despite their statistical significance, and
applying them to the individual patient, remains a
major challenge. It behooves all of us who care for
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615atients to become more precise in our therapeutic
ecision matrix and to rely on more than general-
zed criteria or intuition in the use of new, ex-
remely important, potentially beneficial but yet
xtremely expensive procedures. It is in exactly this
ircumstance that noninvasive imaging can poten-
ially prove exceedingly valuable.
The application of phase analysis to equilibrium
adionuclide angiography is extremely appealing.
lthough the technique has been around for almost
0 years, it has not yet achieved wide clinical use
10,11). The technology basically involves applica-
ion of the fundamental Fourier harmonic to gen-
rate phase and amplitude images. Quantitative
ata are generated as right ventricular and left
entricular phase histograms, which allow the def-
nition of heterogeneity of contraction patterns
oth within each ventricle and between the ventri-
les (12). This approach would seem a good one for
pplication to the study of CRT.
At this point in time, it is important to assess
here this technique stands with respect to use in
atient selection for CRT. The work of Botvinick
t al. (1) addresses the issue of the hemodynamic
elevance of ventricular tachycardia. Although it is
bvious that the technique is also suitable for
pplication to the study of patients considered for
RT, there are no clinical data, let alone clinical
rials, to support this application. Such studies
ould be extremely welcome and potentially quite
aluable. However, the imaging community has not
een standing still on the issue. A number of other
pproaches have been offered to address this partic-
lar problem.
Currently, the most commonly used imaging
odality for the study of CRT is echocardiography.
number of echocardiographic parameters relating
o ventricular desynchronization have been pro-
osed (13). However, at this time, no major pro-
pective trial incorporating echocardiography that
ddresses clinical utility has been undertaken. In
ddition, there appears to be a lack of standardiza-
ion for many, if not all, of the proposed echocar-
iographic parameters.
In a recent review, Anderson et al. (13) high-
ighted this particular problem. Despite a plethora
f publications on the subject, the authors advised
ot to routinely incorporate echocardiographic pa-
ameters into the selection of candidates for CRT.
his recommendation was based upon the absence
f clinical trial data and the conflicting results
oncerning value emanating from smaller studies.
s the authors pointed out, from a clinical stand- voint, it would be more important to identify
onresponders to CRT by using various parameters
ith a high degree of accuracy. However, as stated,
he ideal parameters have yet to be unequivocally
efined. Whether there will be a single echocardio-
raphic parameter or multiple parameters that will
rovide the requisite selection remains to be deter-
ined at this time.
In the light of these considerations, the current
005 American College of Cardiology/American
eart Association Guidelines indicate a Class IA
ndication for CRT in patients with left ventricular
jection fraction 35%, normal sinus rhythm, and
ew York Heart Association functional class 3 to 4
espite optimal medical therapy who manifest car-
iac desynchronization as defined only by a QRS
uration 120 ms (14). Note the absence of incor-
oration of specific imaging parameters of desyn-
hronization, by whatever technique, in this recom-
endation. This recommendation exists despite the
ecognition that using the surface electrocardiogra-
hy alone to detect mechanical asynchrony is im-
erfect (15,16).
Much fewer studies evaluating desynchronization
ave been performed in nuclear cardiology. Inter-
stingly, the principles of phase analysis have been
imilarly applied to electrocardiogram-gated single-
hoton emission computed tomography myocardial
erfusion imaging (17,18). In a recent report by
rimble et al. (18) involving 120 patients with left
entricular dysfunction, several indices indicating
he phase dispersion of the onset of mechanical
ontraction were determined. When compared with
ormal controls, there were significant differences
oted in these 5 parameters. The authors demon-
trated proof of principle concerning potential for
tudying CRT but by no means proceeded to the
ext step, namely using the technology to assess
atient’s suitability for therapy or response to therapy.
In addition, iodine-123 metaiodobenzylguani-
ine (MIBG) also has been studied in a cohort of
0 patients before and at least 3 months after CRT
19). The authors noted that MIBG imaging,
efined as an abnormality in MIBG heart/
ediastinum ratio, could be helpful in defining
atients suitable for CRT. Nonresponders to CRT
ould be identified with a sensitivity of 75% and
pecificity of 71%.
Consequently, the search for the appropriate
oninvasive imaging desynchronization surrogates
or CRT patients continues. There are several
layers on the field. None, to my mind, has pro-
ided the requisite scientific data to mandate clin-
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616cal prime time. The appropriate clinical trial to
efine which technique should play a role in clinical
ecision making has not as yet been performed.
ntil that time, both clinical electrophysiology and
ardiac imaging will continue to be presented with
number of approaches, all with interest, all with
otential, but none with hard data to justify a
roposed clinical role.
This case study is an important one for cardiac
maging. There is a defined clinical need. There are
andidate technologies that appear to offer appro-
riate information that could satisfy that clinical
eed. Specific prospective clinical trials either pri-
arily designed to address the value of imagingal., Comparison of Medical Therapy, adult: summary artirotocols to other CRT clinical trials is the all too
bvious answer. Appropriate funding for such stud-
es must be forthcoming. There is little time to
arry. If this does not occur, cardiac imaging in
RT will continue to provide physiologically
eaningful investigations that set a beautiful table
ut do not deliver the main course.
eprint requests and correspondence: Dr. Barry L. Zaret,
obert W. Berliner Professor of Medicine, Professor of
iagnostic Radiology, Section of Cardiovascular Medi-
ine, Department of Internal Medicine, Yale University
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